African Horse Sickness Treatment Market to Witness Exponential Growth by 2027

African Horse Sickness (AHS) is an acute or mild infection which is non-contagious disease, primarily affecting equine species. The disease is spread by a virus African Horse Sickness Virus (AFSV). African Horse Sickness can cause a mortality rate as high as 95 percent in horses, which are most susceptible to the disease, while mules are less likely, and donkeys are exceptions to African Horse Sickness Disease. A preventive method for African horse sickness treatment is good vaccination program, apart from a good nutritional program and regular deworming which forms an integral part of horse health. Prevention programs are an efficient method and cost effective way to prevent common infectious diseases in a horse.

Request to Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4397

African Horse Sickness Treatment Market: Segmentation

African horse sickness disease is found in four clinical forms and the diagnosis and disease symptoms varied from one form to another. On the basis of various clinical forms of the disease, we can segment the market into the following:

Pulmonary Form or “Dunkop”

Cardiac Form or “Dikkop”

Mixed Form

Horse Sickness Fever

On the basis of diagnosis of the disease and prevention strategies, we can segment the African horse sickness market into:

Diagnosis Tests:

Laboratory Tests for Viral Antigens

Enzyme-linked Immunosorbent Assays (ELISA)

Reverse-transcription PCR assays

Serological Tests

Prevention Treatment

Vaccines

Currently, there is no specific therapy for the treatment of African horse treatment disease and prevention of horses from the disease is recommended. The treatment for African horse sickness is recommended from supportive treatment therapy.

African Horse Sickness Treatment Market: Dynamics

African horse sickness treatment (AHS) market is a growing market for various preventive vaccines in research and development. Additionally, the multivalent, modified-live vaccine does not guarantee the protection of horses from African horse sickness and only decreases the probability of a horse getting the disease.

African Horse Sickness Treatment Market: Region-wise Outlook

Based on geography, the African horse sickness treatment market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the African horse sickness treatment market followed by Europe. The major driving factors which have driven the growth of the African horse sickness treatment market in these regions are the presence of guidelines and standard operating procedures for African horse sickness disease. In U.S.A., organizations such as United States Department of Agriculture (USDA), issues standard operating procedures for the African horse sickness disease. Following North America, European countries are also anticipated to show steady growth in the African horse sickness treatment market.

In the next few years, Asia-Pacific would show remarkable growth in the African horse sickness treatment market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors which would fuel the growth of African horse sickness treatment market in Asia-Pacific are increasing awareness regarding vaccination of horses, rising healthcare infrastructure, and rapid development of the healthcare infrastructure across the Asian countries. African horse sickness treatment market would evolve at a rapid rate across the regions. However, North America would maintain its position in the overall African horse sickness treatment market.

Request Report for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4397

African Horse Sickness Treatment Market: Key Players

It is expected that with due course of time, there will be an influx of well-established players in the African horse sickness treatment market. One of the top players operating in the African horse sickness treatment market is Onderstepoort Biological Products SOC Ltd which manufactures polyvalent African horse sickness vaccine and is licensed in South Africa.

Various institutes are manufacturing vaccine for African horse sickness treatment such as Veterinary Serum and Vaccine Research Institute which is based out in Egypt is manufacturing Bivalent Adjuvant Inactivated African Horse Sickness Vaccine for Type 4, 9 strain. African horse sickness treatment market has a presence of many regional players and research institutes manufacturing vaccines which have a huge market share in emerging countries

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

This release was published on openPR.